Search Results - "Elke Schaeffeler"
-
1
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
Published in Clinical pharmacokinetics (01-07-2015)“…ATP-binding cassette transporter B1 (ABCB1; P-glycoprotein; multidrug resistance protein 1) is an adenosine triphosphate (ATP)-dependent efflux transporter…”
Get full text
Journal Article -
2
Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation
Published in Pharmacology & therapeutics (Oxford) (01-10-2022)Get full text
Journal Article -
3
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy
Published in Clinical and translational science (01-07-2018)“…The solute carrier (SLC) SLC16 gene family comprises 14 members and encodes for monocarboxylate transporters (MCTs), which mediate the absorption and…”
Get full text
Journal Article -
4
Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry
Published in Genetics in medicine (01-09-2019)“…Severe hematotoxicity in patients with thiopurine therapy has been associated with genetic polymorphisms in the thiopurine S-methyltransferase (TPMT). While…”
Get full text
Journal Article -
5
Mechanisms and assessment of statin‐related muscular adverse effects
Published in British journal of clinical pharmacology (01-09-2014)“…Statin‐associated muscular adverse effects cover a wide range of symptoms, including asymptomatic increase of creatine kinase serum activity and…”
Get full text
Journal Article -
6
Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors
Published in Trends in pharmacological sciences (Regular ed.) (01-11-2016)“…Small-molecule inhibitors of tyrosine kinases (TKIs) are the mainstay of treatment for many malignancies and represent novel treatment options for other…”
Get full text
Journal Article -
7
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Published in Trends in pharmacological sciences (Regular ed.) (01-02-2013)“…Metformin is a biguanide derivative used in the treatment of type II diabetes (T2D) and one of the world's most widely prescribed drugs. Owing to its safety…”
Get full text
Journal Article -
8
Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
Published in Hepatology (Baltimore, Md.) (01-10-2009)“…An important function of hepatocytes is the biotransformation and elimination of various drugs, many of which are organic cations and are taken up by organic…”
Get full text
Journal Article -
9
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)
Published in PloS one (14-07-2011)“…Metformin, an oral insulin-sensitizing drug, is actively transported into cells by organic cation transporters (OCT) 1, 2, and 3 (encoded by SLC22A1, SLC22A2,…”
Get full text
Journal Article -
10
Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group
Published in Journal of clinical oncology (01-05-2008)“…To assess the predictive value of polymorphisms in dihydropyrimidine dehydrogenase (DPYD ), thymidylate synthase (TYMS ), and methylene tetrahydrofolate…”
Get full text
Journal Article -
11
Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin
Published in Scientific reports (27-07-2020)“…Effects of different genotypes on the pharmacokinetics of probe substrates may support their use as phenotyping agents for the activity of the respective…”
Get full text
Journal Article -
12
Selective p38α MAP kinase/MAPK14 inhibition in enzymatically modified LDL‐stimulated human monocytes: implications for atherosclerosis
Published in The FASEB journal (01-02-2017)“…ABSTRACT The first ATP‐competitive p38a MAPK/MAPK14 inhibitor with excellent in vivo efficacy and selectivity, skepinone‐L, is now available. We investigated…”
Get full text
Journal Article -
13
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
Published in Molecular cancer therapeutics (01-12-2018)“…The significance of lactate transporters has been recognized in various cancer types, but their role in urothelial carcinoma remains mostly unknown. The aim of…”
Get full text
Journal Article -
14
Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression
Published in Human genetics (01-02-2020)“…Structural variants including copy number variations (CNV) have gained widespread attention, especially in pharmacogenomics but for several genes functional…”
Get full text
Journal Article -
15
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation
Published in Pharmacological research (01-10-2023)“…Solute carrier (SLC) transport proteins are fundamental for the translocation of endogenous compounds and drugs across membranes, thus playing a critical role…”
Get full text
Journal Article -
16
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia
Published in Leukemia (01-09-2021)“…Long-term treatment with 6-thioguanine (6-TG) for pediatric acute lymphoblastic leukemia (ALL) is associated with high rates of hepatic sinusoidal obstruction…”
Get full text
Journal Article -
17
Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
Published in BMC cardiovascular disorders (12-07-2023)“…MicroRNAs are paramount in post transcriptional gene regulation. We investigated platelet miRNAs in patients with CAD and examined potential associations with…”
Get full text
Journal Article -
18
Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B66, is responsible for decreased expression and activity of CYP2B6 in liver
Published in The Journal of pharmacology and experimental therapeutics (01-04-2008)“…CYP2B6 is a polymorphic human drug metabolizing cytochrome P450 with clinical relevance for several drug substrates including cyclophosphamide, bupropion, and…”
Get more information
Journal Article -
19
Reduced Paneth Cell α-Defensins in Ileal Crohn's Disease
Published in Proceedings of the National Academy of Sciences - PNAS (13-12-2005)“…The pathogenesis of Crohn's disease (CD), an idiopathic inflammatory bowel disease, is attributed, in part, to intestinal bacteria that may initiate and…”
Get full text
Journal Article -
20
No association of genetic variants in TLR4, TNF-α, IL10, IFN-γ, and IL37 in cytomegalovirus-positive renal allograft recipients with active CMV infection-Subanalysis of the prospective randomised VIPP study
Published in PloS one (16-04-2021)“…Cytomegalovirus (CMV) infection is amongst the most important factors complicating solid organ transplantation. In a large prospective randomized clinical…”
Get full text
Journal Article